NCT01648985

Brief Summary

In acute stroke patients about 20 % have known diabetes. There is a doubled risk of recurrent stroke in diabetic patients. It has been shown that antiplatelet drugs are not as effective in diabetic patients as in non-diabetic patients. In acute stroke patients around 80 % have impaired glucose tolerance, which will improve after one month till about 60 %. This study includes acute patients with minor stroke or TIA. They are followed up at one and six months and then at every six months for at least four years. The investigators perform an OGTT and haemostatic tests within the first days after onset and then at one month. Blood pressure, metabolic parameters, bodyweight, physical activity and diet are collected at each visit. The investigators give the patients information about lifestyle changes as needed. As part of the study there is an interventional study, Medicine Yoga, an open randomized controlled study. Patients are randomized to 16 sessions of Yoga under professional instructions and a CD for home training or controls. The aims of this study are to investigate glucose tolerance in acute stroke and TIA patients, and its relation to the different haemostatic variables. The importance of glucose tolerance, haemostatic variables and other risk factors (blood pressure, lipids, BMI,) on cardiovascular events will be investigated and the possibility to affect these risk factors by lifestyle changes and Yoga. The effect of different antiplatelet drugs will be investigated in relation to glucose tolerance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

July 18, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 25, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

September 4, 2018

Status Verified

August 1, 2018

Enrollment Period

2.5 years

First QC Date

July 18, 2012

Last Update Submit

August 31, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Stroke (fatal, non-fatal)

    Stroke is defined on clinical ground with support by CT or MR scan

    4 years

Secondary Outcomes (1)

  • Number of patients with Diabetes

    4years

Other Outcomes (1)

  • Number of patients with Small Vessel Disease SVD

    4 years

Study Arms (1)

Acute stroke and TIA patients

Cohort of acute stroke patients, admitted to the Stroke Unit Danderyd hospital 2010 - 2012

Other: Diabetes in stroke/TIA

Interventions

Mostly no intervention. A small Group of the patients recieved Yoga

Acute stroke and TIA patients

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Acute stroke and TIA patients screened from the stroke unit at Danderyd Hospital, Stockholm, Sweden

You may qualify if:

  • Acute minor stroke and TIA patients able to perform OGTT within the first days after onset or having known diabetes.

You may not qualify if:

  • Terminal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet, Daderyd Hospital

Stockholm, S-182 88, Sweden

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 18, 2012

First Posted

July 25, 2012

Study Start

May 1, 2010

Primary Completion

November 1, 2012

Study Completion

November 1, 2016

Last Updated

September 4, 2018

Record last verified: 2018-08

Locations